Volume 9, Number 11—November 2003
Research
West Nile Virus Infection in Nonhuman Primate Breeding Colony, Concurrent with Human Epidemic, Southern Louisiana
Marion S. Ratterree*, Amelia P.A. Travassos da Rosa†, Rudolf P. Bohm*, Frank B. Cogswell*, Kathrine M. Phillippi*, Kevin Caillouet‡, Shelle Schwanberger*, Robert E. Shope†, and Robert B. Tesh†
Table 2
Results of hemagglutination inhibition (HI) tests on blood samples collected in August 2002 from eight West Nile-seropositive rhesus macaques living outdoors at the Tulane National Primate Research Centera
| Animal number (mo bled) | HI antibody titer |
||||
|---|---|---|---|---|---|
| DENV-1 | DENV-2 | YFV | SLEV | WNV | |
| CK62 | 1:40b | 1:20 | 1:20 | 1:160 | 1:320 |
| CL07 | 1:40 | 1:20 | 1:20 | 1:160 | 1:320 |
| CL11 | 1:40 | 1:40 | 1:20 | 1:160 | 1:640 |
| CL80 | 1:40 | 1:40 | 1:40 | 1:160 | 1:640 |
| CL93 | 1:40 | 1:40 | 1:40 | 1:160 | 1:640 |
| CM11 | 1:20 | 1:20 | 0 | 1:20 | 1:80 |
| CP90 | 1:40 | 1:20 | 1:20 | 1:40 | 1:160 |
| CR36 | 1:40 | 1:20 | 1:20 | 1:80 | 1:320 |
aDENV, dengue virus; YFV, yellow fever virus; SLEV, St. Louis encephalitis virus; WNV, West Nile virus.
bHighest positive serum dilution
Page created: April 20, 2012
Page updated: April 20, 2012
Page reviewed: April 20, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.